WX Stock Ownership Activity

WUXI PHARMATECH CAYMAN-ADR 13F holders

No value investing guru has made any change to the WUXI PHARMATECH CAYMAN-ADR (WX) position according to the gurus' latest SEC quarterly report(s).

Which gurus or hedge funds are buying WX now?

According to the latest SEC filing(s) WUXI PHARMATECH CAYMAN-ADR (WX) has not been purchased by any super investor.

To see more about who is investing in WUXI PHARMATECH CAYMAN-ADR (WX), please go to the WX ownership page.

History
Name
Company
%
Activity
Share
Change
% change to
Portfolio
% of
Portfolio
2015 Q4 (1 result)
Sarah Ketterer
Causeway Capital Management
-100.00%
-65,400
-0.06%
0.00%
Reported price*: $43.21
2015 Q3 (1 result)
Sarah Ketterer
Causeway Capital Management
+5.65%
+3,500
+0.00%
0.00%
Reported price*: $43.21
2015 Q2 (1 result)
Sarah Ketterer
Causeway Capital Management
-41.38%
-43,700
-0.05%
0.06%
Reported price*: $41.53
2015 Q1 (1 result)
Sarah Ketterer
Causeway Capital Management
-41.56%
-75,100
-0.08%
0.11%
Reported price*: $38.78
2014 Q3 (1 result)
Sarah Ketterer
Causeway Capital Management
+43.41%
+54,700
+0.07%
0.22%
Reported price*: $35.02
2014 Q2 (1 result)
Sarah Ketterer
Causeway Capital Management
-20.00%
-31,500
-0.04%
0.17%
Reported price*: $32.86
2014 Q1 (1 result)
Sarah Ketterer
Causeway Capital Management
+13.80%
+19,100
+0.03%
0.22%
Reported price*: $31.37
2013 Q4 (1 result)
Sarah Ketterer
Causeway Capital Management
+29.83%
+31,800
+0.07%
0.30%
Reported price*: $38.38
2013 Q3 (1 result)
Sarah Ketterer
Causeway Capital Management
buy
+106,600
+0.24%
0.24%
Reported price*: $27.40
9 of 9

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.